Table 4 HADR frequency of biosimilars and their biologicals authorized by the EMA.
BIOSIMILARS | Very common N (%) | Common N (%) | Uncommon N (%) | Rare N (%) | Very rare N (%) | Not known N (%) | Any frequency N (%) | |
|---|---|---|---|---|---|---|---|---|
INN level | ANY HADR | 6 (31.58) | 10 (52.63) | 7 (36.84) | 8 (42.11) | 2 (10.53) | 3 (15.79) | 14 (73.68) |
ANEMIA | 3 (15.79) | 7 (36.84) | 3 (15.79) | 7 (36.84) | 1 (5.26) | 0 (0.00) | 14 (73.68) | |
LEUCOPENIA | 4 (21.05) | 4 (21.05) | 3 (15.79) | 3 (15.79) | 0 (0.00) | 1 (5.26) | 7 (36.84) | |
THROMBOCYTOPENIA | 4 (21.05) | 4 (21.05) | 4 (21.05) | 4 (21.05) | 0 (0.00) | 1 (5.26) | 10 (52.63) | |
MA level | ANY HADR | 41 (42.71) | 61 (63.54) | 46 (47.92) | 36 (37.50) | 10 (10.42) | 17 (17.71) | 78 (81.25) |
ANEMIA | 25 (26.04) | 35 (36.46) | 20 (20.83) | 35 (36.46) | 4 (4.17) | 0 (0.00) | 79 (82.29) | |
LEUCOPENIA | 33 (34.38) | 23 (23.96) | 12 (12.50) | 20 (20.83) | 0 (0.00) | 6 (6.25) | 45 (46.88) | |
THROMBOCYTOPENIA | 29 (30.21) | 27 (28.13) | 23 (23.96) | 21 (21.88) | 0 (0.00) | 7 (7.29) | 62 (64.58) | |
